Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation

- Joshi, Maansi, Taper, John, Huang, Gillian, Hertzberg, Mark, Forsyth, Cecily, Rowlings, Philip, Campbell, Philip, Crispin, Philip, Harvey, Michael, Underhill, Craig, Bayley, Angela, Byth, Karen

Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: the TOURMALINE-MM3 trial

- Schjesvold, Fredrik, Goldschmidt, Hartmut, Odom, Dawn, Gnanasakthy, Ari, Dimopoulos, Meletios, Maisnar, Vladimir, Spicka, Ivan, Abildgaard, Neils, Rowlings, Philip, Cain, Lauren, Romanus, Dorothy, Suryanarayan, Kaveri, Rajkumar, Vincent

Clinical use of SNP-microarrays for the detection of genome-wide changes in haematological malignancies

- Berry, Nadine K., Scott, Rodney J., Rowlings, Philip, Enjeti, Anoop K.

Detection of complex genomic signatures associated with risk in plasma cell disorders

- Berry, Nadine K., Dixon-McIver, Amanda, Scott, Rodney J., Rowlings, Philip, Enjeti, Anoop K.

Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios

- Saglio, Giuseppe, le Coutre, Philipp, Cortes, Jorge, Mayer, Jiří, Rowlings, Philip, Mahon, François-Xavier, Kroog, Glenn, Gooden, Kyna, Subar, Milayna, Shah, Neil P.

A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia

- Enjeti, Anoop K., D'Crus, Angel, Melville, Kathleen, Verrills, Nicole M., Rowlings, Philip

Comparing outcomes with bone marrow or peripheral blood stem cells as graft source for matched sibling transplants in severe aplastic anemia across different economic regions

- Kumar, Rajat, Kimura, Fumihiko, Inamoto, Yoshihiro, Ichinohe, Tatsuo, Wood Jr., William Allen, Wirk, Baldeep, Seftel, Matthew, Rowlings, Philip, Marks, David I., Schultz, Kirk R., Gupta, Vikas, Dedeken, Laurence, Ahn, Kwang Woo, Hu, Zhen-Huan, Kuwatsuka, Yachiyo, Klein, John P., Pasquini, Marcelo, Miyamura, Koichi, Kato, Koji, Yoshimi, Ayami

To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients

- Hall, Alix E., Paul, Chris, Bryant, Jamie, Lynagh, Marita C., Rowlings, Philip, Enjeti, Anoop, Small, Hannah

Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow

- Berry, Nadine Kaye, Bain, Nicole L., Enjeti, Anoop K., Rowlings, Philip

Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy

- Hughes, Timothy P., Branford, Susan, Cooney, Julian, Leahy, Michael F., Rowlings, Philip, Catalano, John, Hertzberg, Mark, Filshie, Robin, Mills, Anthony K., Fay, Keith, Durrant, Simon, Januszewicz, Henry, White, Deborah L., Joske, David, Underhill, Craig, Dunkley, Scott, Lynch, Kevin, Grigg, Andrew, Reynolds, John, Koelmeyer, Rachel, Seymour, John F., Taylor, Kerry, Arthur, Chris, Schwarer, Anthony K., Morton, James

Influence of age and histology on outcome in adult non-hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): A report from The Center For International Blood & Marrow Transplant Research (CIBMTR)

- Lazarus, Hillard M., Carreras, Jeanette, Rowlings, Philip, Boudreau, Christian, Loberiza Jr., Fausto R., Armitage, James O., Bolwell, Brian J., Freytes, César 0., Gale, Robert Peter, Gibson, John, Hale, Gregory A.